Evommune, Inc. (EVMN) SEC Filings https://ir.evommune.com/financial-information/sec-filings/rss Evommune, Inc. (EVMN) - SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_2094dba4d31887f5c3cda4773c265127/evommune/files/theme/images/logo-sm.png Evommune, Inc. Logo Equisolve Investor Relations Suite <![CDATA[SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors]]> https://ir.evommune.com/financial-information/sec-filings/content/0001757283-26-000018/0001757283-26-000018.pdf Fri, 14 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001757283-26-000018/0001757283-26-000018.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.evommune.com/financial-information/sec-filings/content/0000080255-26-000581/0000080255-26-000581.pdf Fri, 14 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0000080255-26-000581/0000080255-26-000581.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-338017/0001193125-26-338017.pdf Thu, 06 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-338017/0001193125-26-338017.pdf <![CDATA[10-Q - Quarterly report [Sections 13 or 15(d)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337984/0001193125-26-337984.pdf Thu, 06 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337984/0001193125-26-337984.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337964/0001193125-26-337964.pdf Thu, 06 Aug 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-337964/0001193125-26-337964.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-324972/0001193125-26-324972.pdf Thu, 30 Jul 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-324972/0001193125-26-324972.pdf <![CDATA[SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors]]> https://ir.evommune.com/financial-information/sec-filings/content/0000919574-26-004453/0000919574-26-004453.pdf Thu, 16 Jul 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0000919574-26-004453/0000919574-26-004453.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001757072-26-000007/0001757072-26-000007.pdf Fri, 10 Jul 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001757072-26-000007/0001757072-26-000007.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001290976-26-000004/0001290976-26-000004.pdf Wed, 08 Jul 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001290976-26-000004/0001290976-26-000004.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-286924/0001193125-26-286924.pdf Mon, 29 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-286924/0001193125-26-286924.pdf